Napredna pretraga

Pregled bibliografske jedinice broj: 165501

Cystic fibrosis mutations in Croatian CF patients


Barišić, Ingeborg; Gjergja, Romana; Tokić, Višnja; Knežević, Jelena; Sertić, Jadranka
Cystic fibrosis mutations in Croatian CF patients // Cystic Fibrosis European Network - 7th International Symposium for Cystic Fibrosis
Bratislava, 2003. (poster, nije recenziran, sažetak, znanstveni)


Naslov
Cystic fibrosis mutations in Croatian CF patients

Autori
Barišić, Ingeborg ; Gjergja, Romana ; Tokić, Višnja ; Knežević, Jelena ; Sertić, Jadranka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Cystic Fibrosis European Network - 7th International Symposium for Cystic Fibrosis / - Bratislava, 2003

Skup
Cystic Fibrosis European Network - 7th International Symposium for Cystic Fibrosis

Mjesto i datum
Bratislava, Slovačka, 20.09.2003

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
Cystic fibrosis; mutations; Croatia

Sažetak
The frequency of cystic fibrosis (CF) mutations varies among different ethnic groups. Our aim was to determine the frequency of common mutations of CF patients in Croatia, Southern European and Mediterranean country, in order to develop a practical CF mutation panel that can provide maximal information for our population. PATIENTS AND METHODS: A total of 47 CF patients were diagnosed and surveyed at the Children's Hospital Zagreb, Croatia. Most of the patients were screened for 16 common mutations while some of them were screened with INNO LiPa DNA probe assay for 29 CF mutations and Tn polymorphism. RESULTS: Among 47 CF patients were identified 7 different CFTR mutations: Δ F508, F117H, G542X, N1303K, 1717-1G-A, R1162X and 621+1G>T. Δ F508 mutation was present in 66%, which was consistent with Northwest-Southeast gradient within the European population. The G542X and R117H were found each in 3.2% of Croatian CF patients. The N1303K was present in 2.1% while R1162X, 1717-1G-A and 621+1g>T were found each in 1.1% of CF chromosomes. There were 19 Δ F508 homozygotes and 10 compound Δ F508 heterozygotes with severe (3 G542X, 2 N1303K, 1 R1162X, 1 621+1G>T, 1 1717-1G-A) or mild mutation (2 R117H) on other allele. Fifteen CF patients had one mutation unknown (14 N/Δ F508 and 1 N/R117H) while 3 patients have both mutations still unknown. CONCLUSIONS: A total of 79% of CF chromosomes in Croatian CF patients carry 7 different CFTR mutations:Δ F508, R117H, G542X, N1303K, 1717-1G-A, R116X and 621+1G>T. Further studies are necessary to identify other mutations in our population in order to enable more accurate genetic counseling of Croatian CF families and to provide meaningful carrier screening and testing for rare mutations in affected individuals.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
0072165

Ustanove
Klinika za dječje bolesti Medicinskog fakulteta

Citiraj ovu publikaciju

Barišić, Ingeborg; Gjergja, Romana; Tokić, Višnja; Knežević, Jelena; Sertić, Jadranka
Cystic fibrosis mutations in Croatian CF patients // Cystic Fibrosis European Network - 7th International Symposium for Cystic Fibrosis
Bratislava, 2003. (poster, nije recenziran, sažetak, znanstveni)
Barišić, I., Gjergja, R., Tokić, V., Knežević, J. & Sertić, J. (2003) Cystic fibrosis mutations in Croatian CF patients. U: Cystic Fibrosis European Network - 7th International Symposium for Cystic Fibrosis.
@article{article, year = {2003}, pages = {16}, keywords = {cystic fibrosis, mutations, Croatia}, title = {Cystic fibrosis mutations in Croatian CF patients}, keyword = {cystic fibrosis, mutations, Croatia}, publisherplace = {Bratislava, Slova\v{c}ka} }